Sepsis News and Research

Latest Sepsis News and Research

Discovery could lead to new drugs against infection and inflammation

Researchers at Lund University in Sweden, have in collaboration with colleagues in Copenhagen and Singapore, mapped how the body's own peptides act to reduce infection and inflammation by deactivating the toxic substances formed in the process.

13 Aug 2018

MSU researchers uncover the effects of aging on regenerative ability of kidneys

Autophagy is a process of destruction and processing of damaged cell components by the cells themselves. It is used by a cell to clean itself of excessive organelles and sometimes for self-execution. This adaptive mechanism supports a healthy phenotype on the cellular level.

13 Aug 2018

Researchers identify role of infection-fighting cells in inflamed and damaged tissue

Hookworms infect nearly 430 million people in the world, mostly in countries where sanitation is poor, and people often walk barefoot.

7 Aug 2018

Hand washing practices need to step up after bugs resistant to hand sanitizers emerge

All healthcare facilities and hospitals need to step up their hand washing techniques as well as use of alcohol based hand sanitizers after reports of emergence of hospital super bacteria that are becoming more tolerant to alcohol.

2 Aug 2018

LSTM to lead new multinational project on sepsis research in Africa

LSTM is to lead a new multinational project on sepsis following a £2 million award from the National Institute of Health Research.

31 Jul 2018

Research provides new insights about when booster meningitis vaccines are needed

Scientists are indicating that children in Burkina Faso who were vaccinated against group A meningococcal meningitis and septicemia between the ages of 1-4 years in 2010, could need a booster dose of the vaccine as early as this year to ensure they remain protected.

27 Jul 2018

CNDA approves KEYTRUDA for treatment of advanced melanoma

Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.

26 Jul 2018

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck, known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma, met a primary endpoint of overall survival as monotherapy in patients whose tumors expressed PD-L1.

25 Jul 2018

Pediatric sepsis care within an hour increases chances of survival, shows study

More than one in 10 children hospitalized with sepsis die, but when a series of clinical treatments and tests is completed within an hour of its detection, the chances of survival increase considerably, according to a new analysis led by the University of Pittsburgh School of Medicine.

25 Jul 2018

New target for pneumonia seems to restore tight barriers and fluid clearance in the lungs

Severe pneumonia causes a buildup of fluid in the lungs that makes the basics of breathing and getting oxygen out to the body difficult to impossible.

25 Jul 2018

QUT researcher highlights growing impact of non-prescription antibiotics supply in pharmacies

With increased use of antibiotics worldwide linked to growing antibiotic resistance, a world-first study co-authored by a QUT researcher has highlighted the growing impact of non-prescription supply of antibiotics in community pharmacies, and the urgent need for better enforcement of laws.

20 Jul 2018

Bundled-payment system did not lower costs for serious medical conditions, shows study

A payment system that provides financial incentives for hospitals that reduce health-care costs for Medicare patients did not lower costs as intended, according to a new study led by Washington University School of Medicine in St. Louis.

19 Jul 2018

New guide helps hospitals pick right partner to handle hospitalist services

How to Pick a Partner to Manage Your Hospitalist Services is a helpful new guide to the questions hospitals should ask every candidate in order to determine the most qualified partner to manage their hospitalist services.

18 Jul 2018

Engineer patents cost-effective method to remove endotoxins from fluids

By some estimates, 18 million people die each year from sepsis triggered by endotoxins – fragments of the outer membranes of bacteria.

13 Jul 2018

Associate professor receives $1 million grant for disease research

Associate Professor Janelle Ayres is the recipient of a $1 million grant from the W. M. Keck Foundation to study new ways to treat deadly infections including sepsis and the flu, both of which require novel therapies beyond antibiotics and antivirals to effectively combat.

12 Jul 2018

Microfluidic chip to detect sepsis proves successful in clinical study

Two years after inventing a microfluidic chip believed to help detect a life-threatening blood infection, researchers in the Texas Tech University Department of Chemistry & Biochemistry and the Texas Tech University Health Sciences Center are finally seeing their product work successfully for human patients.

10 Jul 2018